Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Jurnal Sinaps
Arthur H.P Mawuntu
Staf, Divisi Neuroinfeksi, Neuroimunologi, dan Neuro-AIDS
Education Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
LITERATURE REVIEW: NEUROLOGICAL ASPECT OF CORONAVIRUS DISEASE 2019 (COVID-19): PART I. OVERVIEW AND PATHOMECHANISM Arthur H.P Mawuntu; Devina C Mastari; Albertus T Lapian; Agnes K.S Hermawan; Mieke A.H.N Kembuan
Jurnal Sinaps Vol. 4 No. 2 (2021): Volume 4 Nomor 2, Juni 2021
Publisher : Neurologi Manado

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (213.987 KB)

Abstract

Since coronavirus disease 2019 (COVID-19) was first reported in China in December 2019, this diseasehas caused a world health crisis and has attracted enormous research interest. The emergence ofneurological manifestations has prompted efforts to understand the COVID-19 pathomechanismsassociated with the nervous system through various studies. This paper discusses the neurological aspectsrelated to COVID-19 infection and neuroinvasion including the underlying mechanisms. Other issuesdiscussed in other parts were clinical manifestations especially associated with neurological aspect, druginteractions as well as disease effects in neurology patients. Understanding this may help manage thepatient.
LITERATURE REVIEW: NEUROLOGICAL ASPECT OF CORONAVIRUS DISEASE 2019 (COVID-19): PART II. CLINICAL MANIFESTATIONS AND DRUG INTERACTIONS Arthur H.P Mawuntu; Devina C Mastari; Albertus T Lapian; Agnes K.S. Hermawan; Mieke A.H.N Kembuan
Jurnal Sinaps Vol. 4 No. 2 (2021): Volume 4 Nomor 2, Juni 2021
Publisher : Neurologi Manado

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (175.172 KB)

Abstract

Coronavirus disease 2019 (COVID-19) was first reported in China in December 2019. This novelvirus has caused a world health crisis with various clinical manifestations. Although the commonmanifestations of COVID-19 infection are fever, cough, malaise, and respiratory problems, there areincreasing reports of clinical manifestations and neurological complications such as decreasedconsciousness, headache, anosmia, stroke, seizures, polyneuropathy, and myopathy. The emergenceof neurological manifestations has prompted efforts to understand the COVID-19 therapies and thepotential drug interactions. Other issues discussed in other parts were pathomechanisms, druginteractions as well as disease effects in neurology patients. Understanding this may help manage thepatient
Co-Authors Agnes K.S Hermawan Agnes K.S. Hermawan Albertus T Lapian Devina C Mastari Mieke A.H.N Kembuan